Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families

Item Type:Article
Title:Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families
Creators Name:Pietschmann, A. and Mehdipour, P. and Mehdipour, P. and Atri, M. and Hofmann, W. and Hosseini-Asl, S. and Scherneck, S. and Mundlos, S. and Peters, H.
Abstract:Purpose: Germline mutations in either BRCA1 or BRCA2 genes are responsible for the majority of hereditary breast and ovarian cancers. At present, over thousand distinct BRCA1 and BRCA2 mutations have been identified. Specific mutations are found to be common within particular populations, resulting from genetic founder effects. To investigate the contribution of germline mutations in these two genes to inherited breast cancer in Iran, we performed BRCA1/BRCA2 mutation analyses in ten Iranian high risk breast cancer families. This is the first study analysing the complete coding sequences of both genes that concerns the Iranian population. Methods: BRCA1/BRCA2 mutation detection included sequencing of the coding and the 3′ and 5′ untranslated regions. To detect large genomic rearrangements in the BRCA1 gene semi-quantitative multiplex PCR was performed. Results: Two pathogenic mutations in the BRCA2 gene were detected: a novel deletion c.4415_4418delAGAA and a previously described insertion c.6033_6034insGT. In addition, one intronic variation g.5075-53C>T and a deletion/insertion g.*381_389del9ins29 in the 3′ untranslated region of BRCA1 were found in two of the investigated families. Both sequence alterations were absent in an age matched Iranian control group. The BRCA2 homozygous variation p.N372H, previously associated with an increased risk for developing breast cancer, was not identified in this study. We did not detect large genomic rearrangements in BRCA1 in patients tested negatively for disease causing mutations in both genes by standard sequencing. Conclusions: At present, the BRCA2 mutations c.4415_4418delAGAA and c.6033_6034insGT have not been identified in any investigated population except the Iranian. Whether both mutations are specific for the Iranian population or a special subgroup remains to be investigated in larger studies. The absence of BRCA1 mutations in the analysed families may suggest that penetrance or prevalence of BRCA1 mutations may be lower in Iran.
Keywords:BRCA1, BRCA2, Breast Cancer, Iran, Mutation, Ovarian Cancer, Unclassified Variants
Source:Journal of Cancer Research and Clinical Oncology
ISSN:0171-5216
Publisher:Springer (Germany)
Volume:131
Number:8
Page Range:552-558
Date:1 January 2005
Official Publication:https://doi.org/10.1007/s00432-005-0678-8
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library